Pulmonary Circulation (Sep 2018)

Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension

  • Shin Watanabe,
  • Kiyotake Ishikawa,
  • Maria Plataki,
  • Olympia Bikou,
  • Erik Kohlbrenner,
  • Jaume Aguero,
  • Lahouaria Hadri,
  • Iratxe Zarragoikoetxea,
  • Kenneth Fish,
  • Jane A. Leopold,
  • Roger J. Hajjar

DOI
https://doi.org/10.1177/2045894018799738
Journal volume & issue
Vol. 8

Abstract

Read online

Nebulization delivery of adeno-associated virus serotype 1 encoding sarcoplasmic reticulum Ca 2+ -ATPase2a (AAV1.SERCA2a) gene was examined in a Yukatan miniature swine model of chronic pulmonary hypertension (n = 13). Nebulization of AAV1.SERCA2a resulted in homogenous distribution of vectors, lower pulmonary vascular resistance, and a trend towards better long-term survival compared to control animals.